Strong association between myotonic dystrophy type 2 and autoimmune diseases

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 11, 2009, Pages 1293-1295

  Tieleman, A A ^a   Den Broeder, A A ^b   Van De Logt, A E ^a   Van Engelen, B G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

ADULT; APLASTIC ANEMIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; CROHN DISEASE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DRUG USE; FAMILIAL DISEASE; FEMALE; GROUPS BY AGE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SMOKING;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; MIDDLE AGED; MYOTONIC DYSTROPHY;

EID: 72249091883     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.156562     Document Type: Article

References (22)

1. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867 (Pubitemid 32743976)
2. Meola G. Clinical and genetic heterogeneity in myotonic dystrophies. Muscle Nerve 2000;23:1789-1799
3. Tieleman AA, van Vliet J, Jansen JBMJ, et al. Gastrointestinal involvement is frequent in myotonic dystrophy type 2. Neuromuscul Disord 2008;18:646-649
4. Udd B, Krahe R, Wallgren-Pettersson C, et al. Proximal myotonic dystrophy - a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 1997;7:217-228
5. Day JW, Ricker K, Jacobsen JF, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-664 (Pubitemid 36246086)
6. Melamies LM, Ruutsalo HM, Nissilä H. Evaluation of a quantitative immunoturbidimetric assay for rheumatoid factors. Clin Chem 1986;32:1890-1894 (Pubitemid 17018066)
7. Zendman AJ, van Venrooij WJ, Pruijn GJ. Use and significance of anti-CCP auto antibodies in rheumatoid arthritis. Rheumatology 2006;45:20-25 (Pubitemid 43033869)
8. Ulvestad E, Kanstrøm A, Madland TM, et al. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand J Immunol 2000;52:309-315 (Pubitemid 30670766)
9. Rijkers GT, Batstra MR, Allebes W, et al. Auto-immuunziekten. Ned Tijdschr Chem Gen Labgeneesk 2006;31:246-248
10. Pagliara S, Spagnuolo E, Ambrosone L, et al. Hyperthyroidism and Addison's disease in a patient with myotonic dystrophy. Arch Intern Med 1985;145:919-920 (Pubitemid 15033261)
11. Bianconcini G, Mazzali F, Guidetti D, et al. Hashimoto's thyroiditis, idiopathic thrombocytopenic purpura (Werlhof's disease) and Steinert's dystrophia myotonica. A clinical case. Minerva Med 1992;83:467-474
12. Maytal J, Spiro AJ, Sinnar S, et al. The coexistence of myasthenia gravis and myotonic dystrophy in one family. Neuropediatrics 1987;18:8-10. (Pubitemid 17079937)
13. Schoen RT. Myasthenia gravis and myotonic dystrophy in a 13-year-old girl. Neurology 1977;27:546-549
14. Fiorito S, Pocobelli D, Antonini G, et al. Auto antibodies in myotonic dystrophy. Allergy Immunol 1989;21:379-380
15. Walker GL, Mastaglia FL, Lane RJ, et al. Immunological studies in myotonic dystrophy. Clin Exp Neurol 1983;19:29-36.
16. Grove DI, O'Callaghan SJ, Burston TO, et al. Immunological function in dystrophia myotonica. BMJ 1973;3:81-83
17. Pan-Hammerström Q, Wen S, Ghanaat-Pour H, et al. Lack of correlation between the reduction of serum immunoglobulin concentration and the CTG repeat expansion in patients with type 1 dystrophia myotonica. J Neuroimmunol 2003;144:100-104 (Pubitemid 37329934)
18. Nakamura A, Kojo T, Arahata K, et al. Reduction of serum IgG level and peripheral Tcell counts are correlated with CTG repeat lengths in myotonic dystrophy patients. Neuromuscul Disord 1996;6:203-210 (Pubitemid 26171263)
19. Suzumura A, Yamada H, Matsuoka Y, et al. Immunoglobulin abnormalities in patients with myotonic dystrophy. Acta Neurol Scand 1986;74:132-139 (Pubitemid 16016610)
20. Roberts DF, Bradley WG. Immunoglobulin levels in dystrophia myotonica. J Med Genet 1977;14:16-19.
21. Olsen NJ. Drug-induced autoimmunity. Best Pract Res Clin Rheumatol 2004;18:677-688
22. Wheeler TM, Thornton CA. Myotonic dystrophy: RNA-mediated muscle disease. Curr Opin Neurol 2007;20:572-576